相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer
Fikri Icli et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
13-cis-retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer -: Report of a pilot phase II study
A. Michael et al.
CLINICAL ONCOLOGY (2007)
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
G. P. Stathopoulos et al.
BRITISH JOURNAL OF CANCER (2006)
Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma
Wes Nakchbandi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patients
JW Blom et al.
EUROPEAN JOURNAL OF CANCER (2006)
Locally advanced pancreatic cancer: Current therapeutic approach
Higinia R. Cardenes et al.
ONCOLOGIST (2006)
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
H Oettle et al.
ANNALS OF ONCOLOGY (2005)
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
M Reni et al.
LANCET ONCOLOGY (2005)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Chemotherapy for colorectal cancer
S Goyle et al.
DIGESTIVE SURGERY (2005)
Incidental detection of pulmonary emboli on routine MDCT of the chest
ML Storto et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
E Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
CMR Lima et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pancreatic cancer and thromboembolic disease
AA Khorana et al.
LANCET ONCOLOGY (2004)
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
MJ Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Nervous system involvement by pancreatic cancer
KS Park et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Adjuvant therapy in pancreatic cancer:: historical and current perspectives
JP Neoptolemos et al.
ANNALS OF ONCOLOGY (2003)
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
JD Berlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
M Ducreux et al.
ANNALS OF ONCOLOGY (2002)
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI5-FU plus mitomycin in inoperable pancreatic cancer
N Maisey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
SR Bramhall et al.
BRITISH JOURNAL OF CANCER (2002)
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma - A prospective, randomized phase III study of the Gruppo Oncologico dell'Italia Meridionale
G Colucci et al.
CANCER (2002)
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial
JP Neoptolemos et al.
LANCET (2001)
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial
SR Bramhall et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression
T Takenoue et al.
ANNALS OF ONCOLOGY (2000)
分享论文
